PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 123 filers reported holding PULMONX CORP in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,821,382 | -23.3% | 950,763 | -2.7% | 0.01% | -21.4% |
| Q2 2023 | $12,812,980 | +2886.7% | 977,344 | +3699.6% | 0.01% | +1300.0% |
| Q3 2022 | $429,000 | +12.3% | 25,722 | -0.8% | 0.00% | – |
| Q2 2022 | $382,000 | -39.0% | 25,923 | -0.2% | 0.00% | -100.0% |
| Q1 2022 | $626,000 | -26.8% | 25,972 | -2.6% | 0.00% | 0.0% |
| Q4 2021 | $855,000 | -22.5% | 26,669 | -13.0% | 0.00% | 0.0% |
| Q3 2021 | $1,103,000 | -19.1% | 30,644 | -0.8% | 0.00% | 0.0% |
| Q2 2021 | $1,363,000 | -6.5% | 30,883 | -3.1% | 0.00% | 0.0% |
| Q1 2021 | $1,458,000 | -34.8% | 31,884 | -1.6% | 0.00% | -50.0% |
| Q4 2020 | $2,237,000 | – | 32,418 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |